Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL002613

Drug Information
NameBrivanib
CompanyBristol-Myers Squibb
IndicationFirst-line liver cancer, liver cancer (TACE) (see also colorectal, sarcoma)
[ICD9: 140-229, 155   ICD10: C00-C96, C22.0]
Phase III    
Metastatic colorectal cancer
[ICD9: 153, 154   ICD10: C18-C21]
Phase II    
SarcomaPhase II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)
16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11
-/m1/s1
InChIKeyWCWUXEGQKLTGDX-LLVKDONJSA-N
Canonical SMILESCC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C    
Isomeric SMILESCC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)O)C
FormulaC19H19FN4O3
PubChem Compound IDCID 11234052.
TargetFGFR
VEGFR



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543